Literature DB >> 3733082

Three day oral course of Augmentin to treat chancroid.

J O Ndinya-Achola, H Nsanze, P Karasira, L Fransen, L J D'Costa, P Piot, A R Ronald.   

Abstract

Amoxycillin and clavulanic acid (Augmentin; Beecham Research Laboratories) was used to treat patients with bacteriologically proved chancroid in three different dose regimens. A single dose of Augmentin (amoxycillin 3 g, clavulanic acid 350 mg) was found to be ineffective. A similar dose repeated after 24 hours was equally ineffective, but a dose (amoxycillin 500 mg, clavulanic acid 250 mg) given every 8 hours for three days was found to be effective. The drug was well tolerated and no side effects were noted in any of the patients treated.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3733082      PMCID: PMC1011938          DOI: 10.1136/sti.62.3.202

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  5 in total

1.  Treatment of chancroid by clavulanic acid with amoxycillin in patients with beta-lactamase-positive Haemophilus ducreyi infection.

Authors:  M V Fast; H Nsanze; L J D'Costa; F A Plummer; P Karasira; I W Maclean; A R Ronald
Journal:  Lancet       Date:  1982-09-04       Impact factor: 79.321

2.  Epidemiologic, clinical, laboratory, and therapeutic features of an urban outbreak of chancroid in North America.

Authors:  G W Hammond; M Slutchuk; J Scatliff; E Sherman; J C Wilt; A R Ronald
Journal:  Rev Infect Dis       Date:  1980 Nov-Dec

3.  Genital ulcers in Kenya. Clinical and laboratory study.

Authors:  H Nsanze; M V Fast; L J D'Costa; P Tukei; J Curran; A Ronald
Journal:  Br J Vener Dis       Date:  1981-12

4.  Antimicrobial therapy of chancroid: an evaluation of five treatment regimens correlated with in vitro sensitivity.

Authors:  M V Fast; H Nsanze; L J D'Costa; P Karasira; I W Maclean; P Piot; W L Albritton; A R Ronald
Journal:  Sex Transm Dis       Date:  1983 Jan-Mar       Impact factor: 2.830

5.  Single-dose therapy of chancroid with trimethoprim-sulfametrole.

Authors:  F A Plummer; H Nsanze; L J D'Costa; P Karasira; I W Maclean; R H Ellison; A R Ronald
Journal:  N Engl J Med       Date:  1983-07-14       Impact factor: 91.245

  5 in total
  5 in total

Review 1.  Antimicrobial susceptibility of Haemophilus ducreyi.

Authors:  Y Dangor; R C Ballard; S D Miller; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

Review 2.  Treatment of chancroid.

Authors:  Y Dangor; R C Ballard; S D Miller; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

3.  Antimicrobial susceptibilities of southern African isolates of Haemophilus ducreyi.

Authors:  Y Dangor; S D Miller; F da L Exposto; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

Review 4.  Beta-lactamase inhibitors from laboratory to clinic.

Authors:  K Bush
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

Review 5.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.